Ausgabe 15-16/2022
Multiple Sklerose
Inhalt (9 Artikel)
editorial
Multiple sclerosis at the crossroads of scientific evidence and clinical translation
Johann Sellner
Open Access
main topic
Retinal imaging with optical coherence tomography in multiple sclerosis: novel aspects
Elisabeth Olbert, Walter Struhal
Open Access
main topic
Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity
Harald Hegen, Klaus Berek, Florian Deisenhammer
main topic
An overview of pivotal trials and real-world evidence for CD20-depleting therapy in multiple sclerosis
Arkady Ovchinnikov, Oliver Findling
Open Access
main topic
Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety
Tobias Moser, Tjalf Ziemssen, Johann Sellner
main topic
Natalizumab treatment during pregnancy in multiple sclerosis—clinical and bioethical aspects of an ongoing debate
Klaus Berek, Claudia Paganini, Harald Hegen, Gabriel Bsteh, Astrid Grams, Michael Auer, Thomas Berger, Florian Deisenhammer, Franziska Di Pauli
Open Access
main topic
Tumefactive demyelinating CNS lesion in a 60-year-old woman with familial Mediterranean fever
Constanze Trostel, Kornelia Laichinger, Till-Karsten Hauser, Sebastian Saur, Markus Krumbholz, Jörg Henes, Ulf Ziemann, Markus C. Kowarik
Multiple Sklerose
themenschwerpunkt
Neuer Masterstudiengang: Multiple Sklerose Management
Isabel Voigt, Christine Stadelmann, Sven G. Meuth, Bernhard Schipp, Peter Flachenecker, Mathias Mäurer, Richard H. W. Funk, Franziska Ramisch, Joachim Niemeier, Tjalf Ziemssen